BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 38757383)

  • 1. Role of N
    Pan J; Tong F; Ren N; Ren L; Yang Y; Gao F; Xu Q
    Oncol Rep; 2024 Jun; 51(6):. PubMed ID: 38757383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functions and mechanisms of N6‑methyladenosine in prostate cancer (Review).
    Wan H; Feng Y; Wu J; Zhu L; Mi Y
    Mol Med Rep; 2022 Sep; 26(3):. PubMed ID: 35856412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silencing of METTL3 effectively hinders invasion and metastasis of prostate cancer cells.
    Chen Y; Pan C; Wang X; Xu D; Ma Y; Hu J; Chen P; Xiang Z; Rao Q; Han X
    Theranostics; 2021; 11(16):7640-7657. PubMed ID: 34335955
    [No Abstract]   [Full Text] [Related]  

  • 4. YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer.
    Li J; Xie H; Ying Y; Chen H; Yan H; He L; Xu M; Xu X; Liang Z; Liu B; Wang X; Zheng X; Xie L
    Mol Cancer; 2020 Oct; 19(1):152. PubMed ID: 33121495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic Investigation of mRNA
    Jiang M; Lu Y; Duan D; Wang H; Man G; Kang C; Abulimiti K; Li Y
    Dis Markers; 2020; 2020():8833438. PubMed ID: 33273988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of the methyltransferase METTL3 in prostate cancer: a potential therapeutic target.
    Zhou X; Chai K; Zhu H; Luo C; Zou X; Zou J; Zhang G
    BMC Cancer; 2024 Jan; 24(1):8. PubMed ID: 38166703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-transcriptional R-loops-mediated epigenetic regulation drives growth retardation and docetaxel chemosensitivity enhancement in advanced prostate cancer.
    Ying Y; Wu Y; Zhang F; Tang Y; Yi J; Ma X; Li J; Chen D; Wang X; Liu X; Liu B; Luo J; Zheng X; Xie L
    Mol Cancer; 2024 Apr; 23(1):79. PubMed ID: 38658974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N
    Huo FC; Zhu ZM; Pei DS
    Cell Prolif; 2020 Nov; 53(11):e12921. PubMed ID: 33029866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNA epigenetics.
    Liu N; Pan T
    Transl Res; 2015 Jan; 165(1):28-35. PubMed ID: 24768686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Four types of RNA modification writers predict the prognosis of prostate cancer.
    Fu W; Ding J; You X; Li Q; Pei X; Qin G
    Andrologia; 2022 Nov; 54(10):e14552. PubMed ID: 36177790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. m
    Huang H; Weng H; Chen J
    Cancer Cell; 2020 Mar; 37(3):270-288. PubMed ID: 32183948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A dynamic reversible RNA N
    Bi Z; Liu Y; Zhao Y; Yao Y; Wu R; Liu Q; Wang Y; Wang X
    J Cell Physiol; 2019 Jun; 234(6):7948-7956. PubMed ID: 30644095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction between N
    Chen Y; Lin Y; Shu Y; He J; Gao W
    Mol Cancer; 2020 May; 19(1):94. PubMed ID: 32443966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The dynamic epitranscriptome: N6-methyladenosine and gene expression control.
    Meyer KD; Jaffrey SR
    Nat Rev Mol Cell Biol; 2014 May; 15(5):313-26. PubMed ID: 24713629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N (6)-Methyladenosine (m(6)A) Methylation in mRNA with A Dynamic and Reversible Epigenetic Modification.
    Wu R; Jiang D; Wang Y; Wang X
    Mol Biotechnol; 2016 Jul; 58(7):450-9. PubMed ID: 27179969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RBM3 suppresses stemness remodeling of prostate cancer in bone microenvironment by modulating N6-methyladenosine on CTNNB1 mRNA.
    Zhang S; Lv C; Niu Y; Li C; Li X; Shang Y; Zhang Y; Zhang Y; Zhang Y; Zeng Y
    Cell Death Dis; 2023 Feb; 14(2):91. PubMed ID: 36750551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. m6A methyltransferase METTL3 promotes the progression of prostate cancer via m6A-modified LEF1.
    Ma XX; Cao ZG; Zhao SL
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3565-3571. PubMed ID: 32329830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multifaceted Roles of the
    Hu C; Liu J; Li Y; Jiang W; Ji D; Liu W; Ma T
    Biomolecules; 2022 Jul; 12(8):. PubMed ID: 36008936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. METTL3 Promotes Tumorigenesis and Metastasis through BMI1 m
    Liu L; Wu Y; Li Q; Liang J; He Q; Zhao L; Chen J; Cheng M; Huang Z; Ren H; Chen J; Peng L; Gao F; Chen D; Wang A
    Mol Ther; 2020 Oct; 28(10):2177-2190. PubMed ID: 32621798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNA m
    Han Z; Yi X; Li J; Zhang T; Liao D; You J; Ai J
    Biochim Biophys Acta Rev Cancer; 2023 Sep; 1878(5):188961. PubMed ID: 37507057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.